Goldman Sachs Group Inc Amneal Pharmaceuticals, Inc. Transaction History

Goldman Sachs Group Inc

$706 Billion
Q2 2025

A detailed history of Goldman Sachs Group Inc transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 2,235,534 shares of AMRX stock, worth $22.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,235,534

Previous 937,189 138.54%

Holding current value

$22.9 Million

Previous $7.85 Million 130.29%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$6.97 - $8.23 $9.05 Million - $10.7 Million	1,298,345 Added 138.54%	2,235,534 $18.1 Million
Q1 2025 May 09, 2025	SELL	$7.72 - $9.01 $282,212 - $329,369	-36,556 Reduced 3.75%	937,189 $7.85 Million
Q4 2024 Feb 11, 2025	BUY	$7.69 - $9.25 $922,384 - $1.11 Million	119,946 Added 14.05%	973,745 $7.71 Million
Q3 2024 Nov 14, 2024	SELL	$6.42 - $8.83 $3.38 Million - $4.65 Million	-526,613 Reduced 38.15%	853,799 $7.1 Million
Q2 2024 Aug 13, 2024	BUY	$5.36 - $7.11 $3.69 Million - $4.89 Million	687,926 Added 99.34%	1,380,412 $8.77 Million
Q1 2024 May 15, 2024	BUY	$5.24 - $6.34 $1.86 Million - $2.25 Million	355,215 Added 105.32%	692,486 $4.2 Million
Q4 2023 Feb 13, 2024	SELL	$3.36 - $6.21 $2.61 Million - $4.83 Million	-777,682 Reduced 69.75%	337,271 $2.05 Million
Q3 2023 May 14, 2024	BUY	$2.76 - $4.59 $2.15 Million - $3.57 Million	777,682 Added 230.58%	1,114,953 $4.71 Million
Q3 2023 Nov 14, 2023	BUY	$2.76 - $4.59 $1.37 Million - $2.28 Million	496,781 Added 80.36%	1,114,953 $4.71 Million
Q2 2023 May 14, 2024	BUY	$1.33 - $3.1 $23,634 - $55,087	17,770 Added 2.96%	618,172 $1.92 Million
Q2 2023 Aug 14, 2023	BUY	$1.33 - $3.1 $23,634 - $55,087	17,770 Added 2.96%	618,172 $1.92 Million
Q1 2023 May 14, 2024	SELL	$1.27 - $2.7 $83,778 - $178,110	-65,967 Reduced 9.9%	600,402 $834,000
Q1 2023 May 11, 2023	SELL	$1.27 - $2.7 $83,778 - $178,110	-65,967 Reduced 9.9%	600,402 $834,000
Q4 2022 May 14, 2024	BUY	$1.96 - $2.61 $101,898 - $135,691	51,989 Added 8.46%	666,369 $1.33 Million
Q4 2022 Feb 13, 2023	BUY	$1.96 - $2.61 $101,898 - $135,691	51,989 Added 8.46%	666,369 $1.33 Million
Q3 2022 May 14, 2024	SELL	$2.02 - $3.62 $271,235 - $486,075	-134,275 Reduced 17.94%	614,380 $1.24 Million
Q3 2022 Nov 10, 2022	SELL	$2.02 - $3.62 $271,235 - $486,075	-134,275 Reduced 17.94%	614,380 $1.24 Million
Q2 2022 May 14, 2024	BUY	$3.01 - $4.46 $1.24 Million - $1.83 Million	411,384 Added 121.97%	748,655 $2.38 Million
Q2 2022 Aug 15, 2022	SELL	$3.01 - $4.46 $106,635 - $158,004	-35,427 Reduced 4.52%	748,655 $2.38 Million
Q1 2022 May 16, 2022	SELL	$3.9 - $4.89 $778,884 - $976,601	-199,714 Reduced 20.3%	784,082 $3.27 Million
Q4 2021 Feb 14, 2022	BUY	$3.95 - $5.85 $170,505 - $252,521	43,166 Added 4.59%	983,796 $4.71 Million
Q3 2021 Nov 10, 2021	BUY	$4.31 - $5.64 $4.05 Million - $5.31 Million	940,630 New	940,630 $5.02 Million

Others Institutions Holding AMRX

# of Institutions

250

Shares Held

146M

Call Options Held

194K

Put Options Held

49.3K

View Full List

About Amneal Pharmaceuticals, Inc.

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.55B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

More about AMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Amneal Pharmaceuticals, Inc. Transaction History